# Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

> **NCT00136565** · PHASE2 · COMPLETED · sponsor: **Lymphoma Study Association** · enrollment: 60 (actual)

## Conditions studied

- Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** Velcade
- **DRUG:** Doxorubicin
- **DRUG:** Prednisone
- **DRUG:** Cyclophosphamide
- **DRUG:** Vindesine
- **DRUG:** Bleomycin

## Key facts

- **NCT ID:** NCT00136565
- **Lead sponsor:** Lymphoma Study Association
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01-08
- **Primary completion:** 2011-04-18
- **Final completion:** 2011-04-18
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136565, "Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00136565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*